About this trial
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients who have already received 2 weeks of peloid therapy or 15 sessions of paraffin treatment will be assessed. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological examinations will also be conducted at the same time points: baseline, 4 weeks post-treatment, and a 12-week follow-up.
Eligibility criteria
Qualifiers
Patients aged between 18 and 65 years old.
Patients diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological evaluations.
Patients experiencing symptoms for a minimum of 3 months.
Disqualifiers
Patients diagnosed with neuropathic conditions such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
Patients with a history of previous injections or surgery for carpal tunnel syndrome.
Trial design
Treatments tested in this trial
- No intervention